Progestogen-only pills and high blood pressure: is there an association? A literature review - PubMed

Review

Progestogen-only pills and high blood pressure: is there an association? A literature review

Sabina F Hussain. Contraception. 2004 Feb.

Abstract

The progestogen-only pill (POP) is a contraceptive option for women who have high blood pressure either induced by use of combined oral pills or due to other causes; as long as it is well controlled and monitored. Combined oral contraception (COC) and Depo-Provera have been implicated in increased cardiovascular risk following use. High blood pressure has been theorized to be the critical path that leads to this increased risk. POP is the recommended method for women who are at risk of coronary heart disease due to presence of risk factors like hypertension. In order to offer POP as a safe, alternative contraception to women who develop hypertension on COCs or those who are at increased cardiovascular risk, it is important to take into account evidence of no association of high blood pressure with POP use. A search of published medical literature (PUBMED and Cochrane database) was undertaken with this objective. A total of four articles were selected for final review after application of inclusion and exclusion criteria. Three of these were prospective control trials and one a cross-sectional survey. There was no randomized study to answer this question. The results of these studies consistently reported no significant association of high blood pressure with use of POPs for up to 2-3 years of follow-up.

Similar articles

• [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].

  Cianci A, De Leo V. Cianci A, et al. Minerva Ginecol. 2007 Aug;59(4):415-25. Minerva Ginecol. 2007. PMID: 17923832 Review. Italian.

• Metabolic and cardiovascular impact of oral contraceptives in polycystic ovary syndrome.

  Soares GM, Vieira CS, de Paula Martins W, Dos Reis RM, de Sá MF, Ferriani RA. Soares GM, et al. Int J Clin Pract. 2009 Jan;63(1):160-9. doi: 10.1111/j.1742-1241.2008.01877.x. Epub 2008 Sep 13. Int J Clin Pract. 2009. PMID: 18795969 Review.

• Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

  Morin-Papunen L, Martikainen H, McCarthy MI, Franks S, Sovio U, Hartikainen AL, Ruokonen A, Leinonen M, Laitinen J, Järvelin MR, Pouta A. Morin-Papunen L, et al. Am J Obstet Gynecol. 2008 Nov;199(5):529.e1-529.e10. doi: 10.1016/j.ajog.2008.04.013. Epub 2008 Jun 4. Am J Obstet Gynecol. 2008. PMID: 18533124

• Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.

  Oelkers WH. Oelkers WH. Climacteric. 2005 Oct;8 Suppl 3:19-27. doi: 10.1080/13697130500330341. Climacteric. 2005. PMID: 16203652 Review.

• Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease.

  Gaffield ME, Kapp N, Curtis KM. Gaffield ME, et al. Contraception. 2009 Oct;80(4):363-71. doi: 10.1016/j.contraception.2009.03.022. Epub 2009 Jun 4. Contraception. 2009. PMID: 19751859 Review.

Cited by

• Hypertension and Reproduction.

  Nilsson PM, Viigimaa M, Giwercman A, Cifkova R. Nilsson PM, et al. Curr Hypertens Rep. 2020 Mar 13;22(4):29. doi: 10.1007/s11906-020-01036-2. Curr Hypertens Rep. 2020. PMID: 32170412 Free PMC article. Review.

• Association between progestin-only contraceptive use and cardiometabolic outcomes: A systematic review and meta-analysis.

  Glisic M, Shahzad S, Tsoli S, Chadni M, Asllanaj E, Rojas LZ, Brown E, Chowdhury R, Muka T, Franco OH. Glisic M, et al. Eur J Prev Cardiol. 2018 Jul;25(10):1042-1052. doi: 10.1177/2047487318774847. Epub 2018 May 10. Eur J Prev Cardiol. 2018. PMID: 29745237 Free PMC article.

• Oral Contraceptive Use, Muscle Sympathetic Nerve Activity, and Systemic Hemodynamics in Young Women.

  Harvey RE, Hart EC, Charkoudian N, Curry TB, Carter JR, Fu Q, Minson CT, Joyner MJ, Barnes JN. Harvey RE, et al. Hypertension. 2015 Sep;66(3):590-7. doi: 10.1161/HYPERTENSIONAHA.115.05179. Epub 2015 Jun 22. Hypertension. 2015. PMID: 26101348 Free PMC article.

• Types of oral contraceptives and breast cancer survival among women enrolled in Medicaid: A competing-risk model.

  Samson ME, Adams SA, Mulatya CM, Zhang J, Bennett CL, Hebert J, Steck SE. Samson ME, et al. Maturitas. 2017 Jan;95:42-49. doi: 10.1016/j.maturitas.2016.10.014. Epub 2016 Oct 22. Maturitas. 2017. PMID: 27889052 Free PMC article.

• Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation.

  Maroo A, Chahine J. Maroo A, et al. Curr Heart Fail Rep. 2018 Jun;15(3):161-170. doi: 10.1007/s11897-018-0392-x. Curr Heart Fail Rep. 2018. PMID: 29616492 Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Medical

  • MedlinePlus Health Information